Pfizer Just Left The Execution Business, Which Means We're Closer To Ending Capital Punishment

This is what corporate responsibility is all about.

In a landmark move, pharmaceutical company Pfizer announced that they are banning their drugs from use in lethal injections.

According to The New York Times, this decision means there are no more open-source drugs for execution in the market.

"Pfizer makes its products to enhance and save the lives of the patients we serve," the company said in a statement, and it "strongly objects to the use of its products as lethal injections for capital punishment."

After the European Union banned the export of execution drugs to the U.S. in 2011, numerous other companies adopted similar policies. Pfizer now joins a list of more than 20 American and European pharmaceutical companies that are out of the execution business.

States have sought out non-FDA-approved drugs for executions, but federal agents are cracking down by seizing them. Last year, a British drug company prohibited Arkansas from using its pharmaceuticals for executions after news of the drug's usage in the state was leaked.

Some states have pushed back execution dates because of the limited availability of the drugs. In 2015, the U.S. executed 28 prisoners. In 2014, there were 31 executions, and in 2013 there were 39.

People on Twitter praised Pfizer's announcement today.

Cover via Spencer Platt/Getty Images.